Metastatic Triple Negative Breast Cancer

Also known as: Metastatic Triple Negative Breast Cancers / Triple Negative Breast Cancer Metastatic / Triple-negative Metastatic Breast Cancer / Metastatic Breast Cancer, Triple Negative Breast Cancer / Triple Negative Metastatic Breast Cancer / Metastatic Triple-negative Breast Cancer / Metastatic Triple-Negative Breast Carcinoma / Triple negative malignant neoplasm of breast (disorder) / Triple Negative Breast Neoplasms / Triple negative breast cancer

DrugDrug NameDrug Description
DB09037PembrolizumabA PD-1 blocking antibody used to treat various types of cancer, including metastatic melanoma, non small-cell lung cancer, cervical cancer, head and neck cancer, and Hodgkin's lymphoma.
DB12893Sacituzumab govitecanSacituzumab govitecan targets TROP-2-expressing cancer cells through a humanized antibody (RS7) before subsequently becoming internalized and releasing the topoisomerase I inhibitor SN-38 to induce DNA damage-mediated apoptosis.
DrugDrug NamePhaseStatusCount
DB00062Albumin human0Withdrawn1
DB11595Atezolizumab0Withdrawn1
DB18028Azenosertib0Withdrawn1
DB11828Neratinib0Not Yet Recruiting1
DB01229Paclitaxel0Withdrawn1
DB08877Ruxolitinib0Not Yet Recruiting1
DB00062Albumin human1Recruiting1
DB11595Atezolizumab1Completed1
DB00307Bexarotene1Recruiting1
DB15387Bintrafusp alfa1Terminated1
DB11666Buparlisib1Completed1
DB08875Cabozantinib1Active Not Recruiting1
DB01101Capecitabine1Recruiting1
DB00958Carboplatin1Active Not Recruiting1
DB00958Carboplatin1Completed1
DB00958Carboplatin1Terminated1
DB00958Carboplatin1Withdrawn1
DB15694Cedazuridine1Recruiting1
DB00531Cyclophosphamide1Recruiting1
DB01262Decitabine1Recruiting1
DB00997Doxorubicin1Recruiting1
DB08871Eribulin1Terminated1
DB17508Hafnium oxide1Recruiting1
DB09035Nivolumab1Active Not Recruiting1
DB09035Nivolumab1Recruiting1
DB09074Olaparib1Active Not Recruiting1
DB09074Olaparib1Completed1
DB06306Onalespib1Completed1
DB01229Paclitaxel1Active Not Recruiting1
DB01229Paclitaxel1Recruiting2
DB01229Paclitaxel1Terminated1
DB09037Pembrolizumab1Recruiting5
DB09037Pembrolizumab1Withdrawn1
DB12552SN-381Completed1
DB00020Sargramostim1Recruiting1
DB09143Sonidegib1Completed1
DB11760Talazoparib1Terminated1
DB13896Talimogene laherparepvec1Completed1
DB00945Acetylsalicylic acid1 / 2Completed1
DB00381Amlodipine1 / 2Completed1
DB11595Atezolizumab1 / 2Completed1
DB11595Atezolizumab1 / 2Terminated1
DB11105Benzalkonium1 / 2Recruiting1
DB11967Binimetinib1 / 2Completed1
DB15387Bintrafusp alfa1 / 2Completed1
DB01101Capecitabine1 / 2Completed1
DB00958Carboplatin1 / 2Completed1
DB00482Celecoxib1 / 2Recruiting1
DB12483Copanlisib1 / 2Active Not Recruiting1
DB00531Cyclophosphamide1 / 2Terminated1
DB01248Docetaxel1 / 2Completed1
DB08871Eribulin1 / 2Active Not Recruiting1
DB01073Fludarabine1 / 2Terminated1
DB05258Interferon alfa1 / 2Recruiting1
DB11743Ipatasertib1 / 2Completed1
DB00602Ivermectin1 / 2Recruiting1
DB01097Leflunomide1 / 2Recruiting1
DB01229Paclitaxel1 / 2Completed2
DB00019Pegfilgrastim1 / 2Completed1
DB09037Pembrolizumab1 / 2Completed1
DB09037Pembrolizumab1 / 2Recruiting1
DB14904Pimasertib1 / 2Completed1
DB16425Rintatolimod1 / 2Recruiting1
DB12893Sacituzumab govitecan1 / 2Recruiting1
DB11942Selinexor1 / 2Recruiting1
DB15106Surufatinib1 / 2Not Yet Recruiting1
DB11760Talazoparib1 / 2Recruiting1
DB11815Tilarginine1 / 2Completed1
DB14922Tislelizumab1 / 2Not Yet Recruiting1
DB11740Adavosertib2Active Not Recruiting1
DB11740Adavosertib2Completed1
DB00062Albumin human2Recruiting1
DB11885Anlotinib2Recruiting1
DB11595Atezolizumab2Recruiting1
DB11105Benzalkonium2Not Yet Recruiting1
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Recruiting1
DB00112Bevacizumab2Terminated1
DB01101Capecitabine2Recruiting1
DB01101Capecitabine2Terminated1
DB12218Capivasertib2Recruiting1
DB00958Carboplatin2Completed1
DB00958Carboplatin2Recruiting3
DB11059Carboxymethylcellulose2Recruiting1
DB04849Cediranib2Active Not Recruiting1
DB14917Ceralasertib2Active Not Recruiting1
DB14917Ceralasertib2Recruiting2
DB14547Chloride ion2Active Not Recruiting1
DB00515Cisplatin2Active Not Recruiting1
DB00515Cisplatin2Completed1
DB16410Datopotamab deruxtecan2Not Yet Recruiting1
DB11714Durvalumab2Recruiting3
DB12078Enobosarm2Completed1
DB08871Eribulin2Recruiting1
DB00783Estradiol2Recruiting1
DB00441Gemcitabine2Recruiting3
DB17293Hiltonol2Recruiting1
DB17542Ligufalimab2Recruiting1
DB00123Lysine2Recruiting1
DB14123Menthol2Active Not Recruiting1
DB09074Olaparib2Active Not Recruiting2
DB09074Olaparib2Recruiting1
DB16265Olinvacimab2Recruiting1
DB01229Paclitaxel2Completed1
DB01229Paclitaxel2Recruiting3
DB01229Paclitaxel2Terminated1
DB17284Pelareorep2Recruiting1
DB09037Pembrolizumab2Completed3
DB09037Pembrolizumab2Not Yet Recruiting2
DB09037Pembrolizumab2Recruiting3
DB12257Platinum2Active Not Recruiting1
DB00571Propranolol2Not Yet Recruiting1
DB15766Retifanlimab2Recruiting1
DB12893Sacituzumab govitecan2Active Not Recruiting1
DB12893Sacituzumab govitecan2Recruiting1
DB12893Sacituzumab govitecan2Withdrawn1
DB11689Selumetinib2Recruiting1
DB08937TAS-1022Withdrawn1
DB09343Tipiracil2Withdrawn1
DB11771Tremelimumab2Recruiting1
DB00432Trifluridine2Withdrawn1
DB15442Trilaciclib2Recruiting1
DB00577Valaciclovir2Completed1
DB07232Veliparib2Active Not Recruiting1
DB00958Carboplatin2 / 3Completed1
DB00441Gemcitabine2 / 3Completed1
DB01229Paclitaxel2 / 3Completed1
DB01128Bicalutamide3Terminated1
DB01101Capecitabine3Completed1
DB08871Eribulin3Completed1
DB00441Gemcitabine3Completed1
DB09037Pembrolizumab3Completed1
DB00361Vinorelbine3Completed1
DB01259LapatinibNot AvailableActive Not Recruiting1
DB05941LeronlimabNot AvailableNo Longer Available1
DB12893Sacituzumab govitecanNot AvailableApproved for Marketing1
DB07232VeliparibNot AvailableActive Not Recruiting1